{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-042070","form_type":"8-K","ticker":"LRMR","cik":"0001374690","company_name":"Larimar Therapeutics, Inc.","filed_at":"2023-08-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:33.735478+00:00","generated_at":"2026-06-11T10:26:42.841875+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"low","headline":"Larimar Therapeutics posts updated investor presentation; no financial results disclosed","bullets":["Company posted an updated slide presentation on its website on August 14, 2023 for use in investor meetings.","No new financial guidance, clinical data, or material business developments were disclosed in the 8-K.","The presentation is filed as Exhibit 99.1 but its full content is not available in the provided text."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-042070","json":"https://secwatch.observer/filing/0000950170-23-042070.json","markdown":"https://secwatch.observer/filing/0000950170-23-042070.md","text":"https://secwatch.observer/filing/0000950170-23-042070.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1374690/000095017023042070/0000950170-23-042070-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1374690/000095017023042070/lrmr-20230814.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-11T10:26:42.841875+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}